U.S. Leisure Stock News

Comcast stock has had a rough five year stretch, yet current valuation checks still flag the shares as looking cheap on several fronts rather than fully pricing in that weaker run. Over the past five years, Comcast shareholders have seen the price decline about 44.6%, which sets expectations low and can create a value driven setup. New partnerships with Fastly and Equinix can support long term cash flow expectations, while execution risk around network investments and streaming quality may...

Taiwan Semiconductor Manufacturing (TSM) just posted record August revenue of NT$514.8 billion, with sales up 53.3% year over year, after artificial intelligence chip demand pushed its foundry business to fresh highs. Recent headlines around Taiwan Semiconductor Manufacturing have been busy, from record August sales tied to AI chips to fresh ETF launches that bundle the foundry alongside peers. The share price at US$433.24 reflects that interest with a 35.55% year to date share price return...

Inflation is heating up again, with gasoline and shelter costs pushing U.S. CPI to 3.4% and markets bracing for another potential Fed rate hike. Rising yields can punish some parts of the market while creating fresh openings elsewhere, which is where many investors get caught flat footed. This article walks through three stocks exposed to this new rate backdrop and explains why they may warrant a closer look in the current environment. The stocks highlighted below are only a small sample of...

Interface has recently reported highly profitable incremental sales, with earnings per share rising about 34.1% annually over the past two years, alongside expanding free cash flow margins and stronger returns on capital. The key story is operational, as Interface converts modest top line gains into much faster earnings growth and this suggests disciplined cost control and capital allocation within its modular flooring and sustainability focused portfolio. We will look at how Interface's...

Coupang’s stock has had a rough run over the past year, yet the current share price screens as cheap on both an intrinsic value check and on market multiples. That mix of a long slide and a high conviction undervaluation signal is what matters for anyone trying to work out what the stock is really worth today. The share price has fallen about 53.3% over the past year, which means the market has already priced in a lot of pessimism. Coupang’s ability to grow cash flow from its e-commerce and...

Marvell Technology has delivered a very large 3 year gain, yet its valuation checks are split, with the Discounted Cash Flow (DCF) intrinsic value pointing to some upside while market based multiples lean expensive. That mix leaves you weighing a stock that has already run hard against indicators that do not all point in the same direction. Over the past 3 years, Marvell Technology has returned about 337.3%, which sets a high bar for any further upside case. The planned acquisition of...

Brinker International (EAT) moved into focus after reporting fourth quarter fiscal 2026 earnings that matched expectations, with revenue ahead of forecasts. Chili's drove results, while Maggiano's contended with softer traffic and restaurant closures. Brinker International’s share price has pulled back recently, with a 7-day share price return down 7.7% and a 30-day return down 13.6%. However, the 90-day share price return of 33.4%, year-to-date gain of 40.2%, and a three-year total...

General Dynamics stock has more than doubled over the past five years, yet both an intrinsic value estimate and earnings multiples still lean toward the shares trading below a cautious appraisal of the business. That mix of strong long term returns and signals of potential undervaluation puts the current US$355.90 price in focus for anyone trying to weigh upside against execution and cash flow risks. The share price has returned 102.6% over five years, which puts General Dynamics in the...

EQT (NYSE:EQT) said a subsidiary won a long term LNG supply tender with Lithuanian energy group UAB Ignitis starting in 2027. The agreement covers LNG cargo deliveries into Lithuania from 2027 through 2036 under a competitive international procurement process. The supply structure provides exposure to both US and European gas price benchmarks for the contracted LNG volumes. This new EQT LNG contract with UAB Ignitis from 2027 to 2036 needs weighing against the rest of our EQT view. Check out...

Meta Platforms (NasdaqGS:META) has agreed to acquire Swedish AI startup Stilla.ai to expand automated business messaging across its apps. The Stilla.ai deal is aimed at boosting AI driven customer support tools on WhatsApp, Messenger and Instagram for commercial users. Meta and other large tech groups are assessing Patagonia in Argentina for new data centers as US community opposition to such projects grows. The Stilla.ai acquisition and Argentina data center review are only part of the...

Academy Sports + Outdoors (NasdaqGS:ASO) has begun offering Hoka performance running shoes in select Southern stores and on its e-commerce platform. The rollout brings a premium running brand into Academy's assortment, widening choice for shoppers who want higher end athletic footwear. The move aligns with Academy Sports + Outdoors' focus on branded merchandise alongside its value offering as it refreshes key categories. The Hoka launch is important, but investors should weigh it alongside...

Exelixis (NasdaqGS:EXEL) reported that the FDA extended its review of the zanzalintinib NDA in metastatic colorectal cancer after new safety and efficacy data submissions. The regulator added time to the review clock following Exelixis' update to the application, which included additional clinical information. Exelixis reached a collaboration milestone with Adagene in their antibody drug conjugate program, triggering a contractual milestone payment. The FDA's extended zanzalintinib review...

Why Flywire’s New Hospitality Partnership Matters Flywire (FLYW) has expanded its relationship with Davidson Hospitality Group, rolling out its payment and e-signature tools across more properties after Davidson reported meaningful processing fee savings and faster guest deposit and contract workflows. Recent trading shows Flywire’s 90-day share price return of 21.48% and year-to-date gain of 28.56% have been strong, while the 1-year total shareholder return of 33.86% contrasts with a 3-year...

Recent commentary on Danaher (DHR) has focused on the stock’s limited upside compared with the S&P 500, tying that underperformance to concerns around organic revenue trends, margins, and earnings per share. Over the past year Danaher has delivered a 6.1% total shareholder return, even though the share price is down 13.1% year to date and recently eased from its 90 day gain of 11.1%. This points to fading short term momentum despite a more resilient longer term picture when dividends are...

C.H. Robinson Worldwide has delivered a strong 5 year run for shareholders, yet current valuation checks suggest the stock now trades at a premium to what its intrinsic value estimate implies. The share price return of 95.7% over 5 years points to a business that investors have rewarded heavily. Management’s handling of the US$604m legal verdict and potential insurance cost pass through can influence how investors think about future cash flows and risk. The company screens as overvalued on...

Paychex (PAYX) has drawn investor attention after recent price moves and mixed short term returns. The payroll and HR services stock last closed at $115.80, with performance varying sharply between the past month and the past 3 months. Recent trading suggests momentum for Paychex is softening in the short run, with the share price down 4.9% over the past week and 3.8% over the past month. This comes even though the 3 month share price return of 15.1% and 3 year total shareholder return of...

BridgeBio Pharma (BBIO) returned to focus after fresh PROPEL 3 data on oral infigratinib in achondroplasia, with management highlighting 52 week trends in sleep apnea, ear infections, growth and body proportionality. BridgeBio Pharma’s latest PROPEL 3 update lands after a choppy stretch in the market, with the share price at US$72.44 and a 30 day share price return down 13.6%, even as the 1 year total shareholder return is up 41.46% and the 3 year total shareholder return is up 148.68%. This...

Lemonade (LMND) just broadened its footprint, rolling out renters insurance in Kentucky and Kansas, alongside Lemonade Car and an Autonomous Car pricing program for Missouri Tesla drivers. Lemonade is expanding into new states at a time when momentum in the share price has cooled, with the stock down 7.5% over the past week and 35% year to date on a share price basis, even as the three-year total shareholder return remains very large. Scan beyond Lemonade and see how other insurers are being...

Sensata Technologies recently introduced its OmniNode high voltage power distribution platform for commercial vehicles and its R290 Pressure + Temperature Sensor for electrified thermal systems, both aimed at simplifying engineering, meeting safety rules and supporting OEM adoption of new architectures and refrigerants. These launches push Sensata Technologies further into system level solutions, where combining multiple functions in one module can affect content per vehicle, customer...

Unity Software (U) is back in focus as the next earnings report approaches and Wall Street weighs projected jumps in earnings per share and revenue against weaker long term growth, softer billings and thinning margins. Recent trading has been choppy. Unity Software’s share price has climbed 61.4% over the past 90 days and the 1 year total shareholder return is 0.9%. However, the 5 year total shareholder return is still down 67.8%, which signals that momentum has picked up in the short term...

Molina Healthcare comes into focus as a stock with solid gains over the past year but a sharp decline of about 38% over three years, while its valuation checks still flag it as cheap on the broader metrics. Recent revenue pressure and customer losses have unsettled sentiment, yet the current pricing screens as undervalued on core multiples. The share price has fallen roughly 38% over three years, which suggests longer term holders have absorbed a heavy drawdown that is not fully reflected in...

Denali Therapeutics has delivered a strong 1 year rebound for shareholders, yet multiple valuation checks suggest the current share price sits above where an intrinsic value estimate and market based comparisons would place it. The stock therefore looks priced for meaningful execution on its drug pipeline even after a difficult 5 year stretch. Over 5 years, Denali Therapeutics shareholders have seen the investment fall about 60%, which hints that earlier optimism has not yet translated into...

Carlyle Group (CG) is back in focus after portfolio company Exiger rolled out its AI native 1Exiger platform, following a US$1.2b investment round that involved Carlyle and other backers. Despite Exiger’s AI push grabbing headlines, Carlyle Group’s recent share price performance has been weak. The stock is down 12.29% over 30 days and 30.43% year to date, while a 3-year total shareholder return of 38.05% shows a more constructive longer-term record. Scan other private markets and AI exposed...

Clorox (CLX) has come under pressure recently, with the share price down 17% over the past month and 9% in the past 3 months. This has put the consumer staples group back under the microscope for investors. Zooming out, Clorox’s 1-year total shareholder return is down 25.63%, and the 3-year and 5-year total shareholder returns are also lower. This suggests that recent weakness in the share price is part of a longer period of fading momentum around the stock. Compare Clorox’s recent slide with...